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Abstract
Paraoxonase (PON) gene polymorphisms have been proposed as genetic markers of risk for cardiovascular disease (CVD).
Sporadic results suggest they are correlated with intima-media thickness (IMT), an indicator of preclinical atherosclerotic disease.
We have investigated whether polymorphisms PON 1 (M/L) 55, (Q/R) 192, PON 2 (S/C) 311 are related to site-specific carotid
plaques in 310 middle-aged women. Subjects were also investigated for physical and biochemical parameters including oxidative
markers to evaluate their effect on development of atherosclerotic plaques (IMT/1.2 mm) identified by high resolution B-mode
ultrasound. We demonstrate that PON 1 (LL/ML) 55 is associated with plaques both at the bifurcation (OR/2.40; 95% CI 1.00/
5.90) and at the common carotid artery (OR/2.75; 95% CI 1.01/7.50), and to the total number of plaques at any site (PB/0.05).
This polymorphism is an independent parameter with respect to other variables that are significantly associated with plaques, i.e.
systolic blood pressure (OR/2.06; 95% CI 1.11/3.81) and oxidized low-density lipoprotein (LDL) antibodies (OR/1.96; 95% CI
1.05/3.69) in cases of common carotid plaques, and lipid peroxides (OR/1.86; 95% CI 1.00/3.50) in cases of bifurcation plaques.
In conclusion, PON 1 (LL/ML) 55 but not PON 1 (Q/R) 192 or PON 2 (S/C) 311, appears to be an independent risk factor for
increased carotid IMT in middle-aged women.
# 2002 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
Many genes, including the human paraoxonase gene
(PON), have been implicated in cardiovascular disease
(CVD) [1/3]. Three PON genes (PON 1, PON 2, PON
3) have been identified and mapped to chromosome 7
[4]. Polymorphisms have been detected at codons 192
(Gln0/Arg, Q/R) and 55 (Met0/Leu, M/L) in the PON
1 gene, and at codon 311 (Ser0/Cys, S/C) in the PON 2
gene [5,6]. PON (E.C. 3.1.1.2) is a Ca2-dependent
glycoprotein bound to high-density lipoproteins (HDL)
and it may enhance their anti-atherosclerotic properties.
In fact, PON prevents in vitro lipid peroxidation of low-
density lipoproteins (LDL) [7] and PON 1 knockout
mice have enhanced susceptibility to atherosclerosis [8].
Moreover, PON 1 hydrolyzes lipid peroxides in human
atherosclerotic lesions [9]. The association between PON
1 and 2 gene polymorphisms and CVD has been
investigated in Caucasian and non-Caucasian popula-
tions [6,10/14]. Unfortunately, the results have been
discordant, probably due to the selection criteria of
cases and controls.
High resolution B-mode ultrasound is a valid and
reliable method to detect and monitor changes in carotid
intima-media thickness (IMT), a marker of preclinical* Corresponding author. Tel./fax: /39-081-746-3541.
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generalized atherosclerosis. Increased carotid IMT, i.e.
thickenings and plaques, has been found in subjects with
cardiovascular risk factors, and it is correlated with the
presence of coronary atherosclerosis as an independent
predictor of cardiovascular events [15/17]. The finding
of genetic markers related to IMT, in addition to
traditional risk factors and oxidation markers such as
oxidized LDL antibodies, lipid peroxides, and 8-iso-
PGF2a, might be useful to better identify people at high
cardiovascular risk [14,15,18].
In this context, we studied PON 1 and 2 gene
polymorphisms in relation to carotid plaque occurrence
(evaluated with B-mode ultrasonography) and to other
cardiovascular risk factors such as oxidation markers in
310 middle-aged women from South Italy enrolled in the
Atena project [19].
2. Materials and methods
2.1. Subjects
The Atena project is a prospective study carried out in
the Naples area (Italy). The total cohort, enrolled over 4
years, consisted of 5062 women aged between 30 and 71
years. Medical histories, including cardiovascular and
metabolic disease and smoking habit, were collected
from all subjects. Subjects with a previous diagnosis of
myocardial infarction, stroke and major cancers were
not included in the cohort. No selected women took
hormone replacement therapy or were pharmacologi-
cally treated for diabetes or hypertension. Over 6
months, the older three of ten daily participants were
offered a free vascular examination (high resolution
ultrasound of the carotid arteries). The 310 women who
accepted (77% response rate) underwent the PON
genetic study described herein. There were no significant
differences in the cardiovascular risk profile between the
whole cohort and this subsample [15]. The study was
approved by the Ethics Committee of our Medical
School, and informed consent was obtained for each
patient.
2.2. B-mode ultrasound
An internationally certified sonographer made the
carotid B-mode ultrasound examinations using the
Biosound 2000 II SA apparatus equipped with an 8
MHz anular array mechanical transducer. The system
provides high-resolution ultrasonic images with 0.3-mm
axial resolution and 2568 of gray scale. Scans were
performed according to a standardized protocol detailed
elsewhere [15]. Briefly, the aim of the protocol was to
measure IMT in the distal 1 cm of the common carotid
artery and the carotid bifurcation; an IMT/1.2 mm
was indicative of plaques (ultrasound end-point of the
study). This cut-off point has been used in randomized
clinical trials [20] and corresponds to the 90th percentile
of the mean IMT of a random sample of 170 adult
Neapolitan women. The sonographer looked for carotid
plaques on the near and far walls of the common carotid
arteries and carotid bifurcations at both sites. The total
number of plaques at both sites is ‘plaque score’. All
IMT measurements were made by the sonographer at
the time of the examination using an electronic caliper,
as previously reported, the within-subject coefficient of
variation was B/6% [21].
2.3. DNA analysis
Genomic DNA was extracted from peripheral blood
samples according to standard techniques [22]. DNA
was available for 288 women (93% of total sample). The
Gln-Arg 192 and Met-Leu 55 polymorphisms at PON 1
and the Ser-Cys 311 polymorphism at PON 2 were
determined after polymerase chain reaction (PCR)
amplification followed by digestion with Alw I, NlaIII
and DdeI, for the three polymorphisms respectively
[5,6]. The PCR products were resolved on a metaphore
gel 4% and visualized by staining with ethidium
bromide. PON genotypes were assessed independently
by two observers. The identity of PCR products was
verified by sequence analysis.
2.4. Anthropometry and laboratory measurements
The body mass index (BMI) was calculated for each
subject as body weight (kg) divided by squared height
(m2). Venous blood was sampled from all subjects, after
an overnight fast. Serum total cholesterol, triglycerides
and glucose were evaluated enzymatically on an auto-
mated analyzer (Hitachi 747, Boehringer Mannheim,
Germany). HDL cholesterol was determined enzymati-
cally by measuring cholesterol in the supernatant after
precipitation with phosphotungstate. LDL cholesterol
levels were calculated according to the traditional
Friedewald formula [23]. The serum IgG antibody titer
against oxidized LDL was measured in duplicate with
an enzyme-linked-immunosorbent-assay (ELISA) on
microwells coated with Cu2 oxidized-LDL (o-Lab-
ELISA Kit, Biomedica, Vienna, Austria). The results
were expressed as mU/ml. Imprecision coefficients
(intra- and inter-assay), evaluated on control sera at
low and high concentrations, were below 10%.
Total radical-trapping antioxidant plasma activity
(TRAP) was measured with a spectrophotometric end-
point method on a Cobas/Fara analyzer [24]. The
synthetic water-soluble tocopherol analogue Trolox
(Hoffman/La Roche) was used for calibration. The
intra- and inter-assay imprecision coefficients, evaluated
on a plasma pool, were 1.7 and 3.2%, respectively.
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The concentration of thiobarbituric acid (TBA)
reactive substances was measured with a modified
TBA assay [25] and the results were quantified on the
basis of a calibration curve obtained with the standard
malondialdehyde, the main product of lipid peroxida-
tion.
2.5. Statistical analysis
Allele frequencies were calculated by allele counting
and the departure from Hardy/Weinberg expectation
was evaluated by x2 analysis. The relationship of the
PON gene polymorphisms with continuous variables
was tested by one-way ANOVA. The relationship
between PON gene polymorphisms and categorical
variables was identified by the x2-test. The Bonferroni
correction was used to make comparisons [26]. To
compare groups with and without plaques at different
sites, biochemical and physical parameters were divided
into quartiles. PON gene polymorphisms were combined
as follows: PON 1 MM (55) (group/0) versus LL/ML
(group/1), PON 1 QQ (192) (group/0) versus QR/
RR (group/1) and PON 2 SS (311) (group/0) versus
SC/CC (group/1). Odds ratios (OR) of atherosclero-
tic plaques were determined by logistic regression
analysis comparing group 0 versus group 1 for each
polymorphism and quartile 4 versus quartiles 1/3 of
biochemical and physical parameters; 95% confidence
intervals (CI) were calculated from the b -coefficients
and their standard errors after adjustment for age,
smoking, LDL cholesterol and BMI.
The interaction between smoking habit, plaques and
polymorphisms was also evaluated by logistic regression
analysis.
Multiple linear regression analysis was used to
investigate the relationship between the total number
of plaques at both sites (plaque score) and each of the
tested biochemical, physical and genetic (PON poly-
morphisms) characteristics. Statistical analyses were
performed using the SPSS for WINDOWS software (Ver-
sion 9.0).
3. Results
In a previous paper [15] concerning the Atena
population we reported that there were no atherosclero-
tic plaques (IMT/1.2 mm) at either the bifurcation or
the common carotid artery in 105 women; in the
remaining 205 subjects, plaques were found at the
bifurcation (n/77), at the common carotid artery
(n/37) or at both sites (n/91). Table 1 summarizes
the characteristics of the study sample. Most physical
and biochemical variables did not differ significantly
depending on the presence or absence of plaques.
Differently, LDL-cholesterol, total cholesterol levels
(PB/0.01) and lipid peroxides (PB/0.05) were asso-
ciated with plaques at the bifurcation, and blood
pressure (PB/0.05), BMI and oxidized LDL antibodies
(PB/0.01) were associated with plaques at the common
carotid artery.
Table 2 shows the distribution of the Gln-Arg (Q/R)
192 and Met-Leu (M/L) 55 polymorphisms at the PON
1 locus and the Ser-Cys (S/C) 311 polymorphism at the
PON 2 locus, together with the corresponding allele
frequencies. All three genotypes, at each locus, followed
the Hardy/Weinberg equilibrium. The Q (192), L (55)
and S (311) alleles were present in, respectively 68, 65
and 81% of the observed genotypes.
There were no significant differences (data not shown)
between traditional cardiovascular risk factors, oxida-
tion markers and Q/R (192), M/L (55) PON 1 or S/C
(311) PON 2 polymorphisms with the only association
with age for M (55) allele carriers (PB/0.017 by
ANOVA).
The percentages of genotypes QQ (192), MM (55)
PON 1 and SS (311) PON 2 were higher in the absence
than in the presence of plaques (Table 3). However, only
the MM (55) genotype was significantly associated with
plaques at the bifurcation (P/0.05) and at the common
carotid (PB/0.03). In non smokers MM was signifi-
cantly associated with less plaque formation (P/0.025)
at any site, whereas in smokers MM was associated with
greater plaque formation, which suggests that the
protective role of MM genotype is lost in these subjects.
We then used logistic regression analysis, after data
adjustment for age, smoking, LDL cholesterol and BMI,
to test the association between the site of atherosclerotic
plaques and PON 1 and 2 genotypes, and physical and
biochemical parameters (detailed in Table 1). As shown
in Figs. 1 and 2, PON 1 (LL/ML) genotypes were
significantly associated with plaques, both at the bifur-
Table 1
Physical and biochemical characteristics of the sub-sample of the
Atena project population of middle-aged women (n/310)
Parameter Mean9/S.D.
Age (years) 55.09/7.81
BMI(kg/m2) 27.79/4.57
Systolic blood pressure 140.29/22.13
Diastolic blood pressure 83.39/10.57
Smokers n (%) 71 (43.8)
Total cholesterol (mmol/l) 6.399/1.35
LDL cholesterol (mmol/l) 4.089/1.22
HDL cholesterol (mmol/l) 1.659/0.41
Triglycerides (mmol/l) 1.389/0.71
Glucose (mmol/l) 5.589/1.09
Oxidized LDL antibodies (mU/ml) 3309/292.03
TRAP (mmol/l) 1.539/0.11
Lipid peroxides (mmol/l) 0.469/0.19
BMI, body mass index; TRAP, total radical-trapping antioxidant
plasma activity; LDL, low-density lipoproteins; HDL, high-density
lipoproteins.
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cation (OR 2.40; 95% CI 1.00/5.90) and at the common
carotid (OR 2.75; 95% CI 1.01/7.50). Plaques at the
bifurcation were also associated with lipid peroxides
(OR 1.86; 95% CI 1.00/3.50), whereas common carotid
plaques were associated with oxidized LDL antibodies
(OR 1.96; 95% CI 1.05/3.69) and systolic blood
pressure (OR 2.06; 95% CI 1.11/3.81). PON 1 (QR/
RR) and PON 2 (SC/CC) genotypes did not differ in
relation to plaques whatever the site. Finally, multiple
linear regression analysis of physical and biochemical
characteristics, and PON 1 and 2 polymorphisms (after
adjustment for the confounding parameters age, smok-
ing, LDL cholesterol and BMI) in relation to plaque
score revealed that the latter was related to the PON 1
(LL/ML) genotypes and systolic blood pressure (Table
4). We investigated the effects of interaction between
PON 1 and 2 polymorphisms versus plaques, but did not
identify any significant risk carrier genotype.
4. Discussion
We have studied PON 1 and 2 polymorphisms, IMT
and other traditional and non-traditional risk factors for
CVD in a large sample of middle-aged clinically healthy
women (310 subjects from more than 5000 of the Atena
project). PON 1 activity has recently been reported to be
a better predictor of CHD than PON polymorphisms
[27]. The aim of our study was to explore the role of
PON in plaque evolution, in the absence of cardiovas-
cular events, in healthy women. To this aim we
investigated PON genotypes as a predictor of the ability
of PON to prevent LDL oxidation [7], rather than PON
1 activity, which reflects the enzyme’s ability to hydro-
lyze organophosphate such as paraoxon and not its
antioxidant capacity [2].
The results show that PON 1 genotypes play an
important role in the early formation of atherosclerotic
Table 2
Genotype and allele distributions of Gln-Arg (Q/R) 192, Met-Leu (M/L) 55 PON 1 and Ser-Cys (S/C) 311 PON 2 polymorphisms in a subsample of
middle-aged women of the Atena project
PON 1 PON 2
Q/R 192 (n/286) M/L 55 (n/288) C/S 311 (n/287)
Q/Q 140 (49%) L/L 119 (41%) S/S 188 (66%)
Q/R 111 (39%) M/L 136 (47%) S/C 90 (31%)
R/R 35 (12%) M/M 33 (12%) C/C 9 (3%)
Q allele 391 (68%) L allele 374 (65%) S allele 466 (81%)
R allele 181 (32%) M allele 202 (35%) C allele 108 (19%)
Table 3
Allele distribution of Met-Leu (M/L) 55, Gln/Arg (Q/R) 192 PON 1 and Cys/Ser (C/S) 311 PON 2 in women of the Atena project, in presence (IMT
/1.2 mm) and absence of plaques (IMT5/1.2 mm) at any site, bifurcation and common carotid artery
Any site Bifurcation Common carotid artery
IMT/1.2 mm IMT5/1.2 mm IMT/1.2 mm IMT5/1.2 mm IMT/1.2 mm IMT5/1.2 mm
PON 1 (55) (n/192) (n/96) (n/153) (n/135) (n/120) (n/168)
Genotype
L/L 82 (43%) 37 (38%) 65 (43%) 54 (40%) 50 (42%) 69 (41%)
M/L 94 (49%) 42 (44%) 77 (50%) 59 (44%) 63 (52%) 73 (43%)
M/M 16 (8%) 17 (18%) 11 (7%) 22 (16%) 7 (6%) 26 (16%)
P/n.s P/0.05 PB/0.03
PON 1 (192) (n/190) (n/96) (n/151) (n/135) (n/118) (n/168)
Genotype
Q/Q 88 (46%) 52 (54%) 69 (46%) 71 (53%) 56 (47%) 84 (50%)
Q/R 76 (40%) 35 (37%) 58 (38%) 53 (39%) 47 (40%) 64 (38%)
R/R 26 (14%) 9 (9%) 24 (16%) 11 (8%) 15 (13%) 20 (12%)
P/n.s P/n.s P/n.s
PON 2 (311) (n/191) (n/96) (n/152) (n/135) (n/119) (n/168)
Genotype
C/C 7 (4%) 2 (2%) 5 (3%) 4 (3%) 6 (5%) 3 (2%)
C/S 63 (33%) 27 (28%) 51 (34%) 39 (29%) 43 (36%) 47 (28%)
S/S 121 (63%) 67 (70%) 96 (63%) 92 (68%) 70 (59%) 118 (70%)
P/n.s P/n.s P/n.s
n.s/not significant.
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plaques. In fact, we demonstrate that PON 1 (LL/ML)
55 genotypes were associated with plaques both at the
bifurcation and at the common carotid artery, and with
plaque score. This polymorphism is an independent
parameter with respect to other variables that are
significantly associated with plaques, i.e. systolic blood
pressure and oxidized LDL antibodies (plaques at the
common carotid), and lipid peroxides (plaques at the
bifurcation).
The frequencies of PON 1 M/L (55) genotypes were
similar to those reported for other Caucasian popula-
tions [10,28/30] and differed from Asiatic [12] and
Mestizos [31] populations whose MM genotype was
respectively less (1%) and more (56%) frequent than in
our sample (12%). Thus, our findings support the
concept that PON 1 polymorphisms vary according to
ethnic provenance. In about one-third of women free
from plaques, the frequency of PON 1 MM (18% at any
site, and 16% at both the bifurcation and common
carotid) was higher than in the total population (12%),
which agrees with the hypothesis that the MM genotype
affords more protection against atherosclerosis than do
the LL and LM genotypes. Accordingly, in in vitro
experiments, PON 1 MM associated with HDL pro-
vided greater protection against LDL oxidative changes
(49.5%) than LL and ML (respectively, 21.8 and 29.5%).
These data support a similar susceptibility to lipid
peroxidation of subjects bearing PON 1 ML or LL
genotypes [7]. In addition, as indicated above, we found
that the PON 1 (LL/ML) 55 genotypes were signifi-
cantly associated with plaque score, thus providing
direct evidence for an increased risk in women in the
early phase of blood vessel atheroma formation.
Earlier studies of Caucasian populations established
that PON 1 LL (55) alone or associated with PON 1 QQ
(192) were risk factors for atherosclerosis evaluated by
IMT [29,32,33]. However, studies on the role of the
PON 1 M/L (55) polymorphism and CVD produced
conflicting results [10,12,34,35]. Different inclusion
criteria for CVD cases (i.e. myocardial infarction, /
50% stenosis of major coronary arteries, familial hy-
percholesterolemia, etc.), or lack of appropriate control
groups (i.e. selection based on normal ECG, absence of
family history of CVD, medical history based on
questionnaire, etc.), together with the specific ethnic
characteristics of the populations examined may explain
these discordant findings.
We previously found in the same Atena sample that
common carotid artery plaques were significantly asso-
ciated with higher systolic blood pressure, BMI and
increased levels of antibodies to oxidized LDL, whereas
higher LDL cholesterol and lipid peroxidation products
Fig. 1. Odds ratio and 95% CI obtained by logistic regression analysis of carotid bifurcation plaques, PON 1 (M/L, Q/R), PON 2 (S/C)
polymorphisms, physical and biochemical parameters (quartile 4 versus quartiles 1/3) in the study sample. The data were adjusted for age, smoking,
LDL cholesterol and BMI. Statistically significant association was found only among PON1 (LL/ML) genotypes and upper quartile 4 of values for
lipid peroxides.
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were associated with plaques at the carotid bifurcation
when compared with results from women without
plaques [15]. These results suggest that different me-
chanisms underlie lesion development. In fact, the
bifurcation segment, which contains more macrophages
compared with contiguous segments, appears to be more
susceptible to LDL oxidation and lipid accumulation as
shown by high levels of lipid peroxidation. Although
associated with medial hyperplasia due to hypertension,
the common carotid artery is far from being susceptible
to atherosclerosis. Therefore, common carotid plaques
are likely to be related to atherosclerotic progression
marked by high titers of oxidized LDL antibodies.
These data, and the association of the PON 1 (55)
polymorphism with plaques at both the bifurcation and
common carotid and with plaque score reported herein,
support the hypothesis that genetic PON predisposition,
lipids and their oxidative status in blood, and hyperten-
sion are all involved in the development of athero-
sclerosis.
We found no association between the PON 1 (RR/
RQ) 192 genotype and plaques even if in our patients
with IMT/1.2 mm the RR/RQ genotypes were more
frequent than in patients with IMTB/1.2 mm. Similarly,
two studies of a clinically healthy population failed to
show an association between the PON 1 (192) poly-
morphism and carotid lesions [32,36]. On the other
hand, a meta-analysis showed that PON 1 (RR or RQ)
192 genotypes were significantly increased if CVD was
present [2]. Perhaps, as previously suggested [36], the
effect of PON 1 Q/R (192) genotypes on plaque
formation differs between the early and later stages of
the atherosclerotic process.
Another result of our study concerns the PON 2 S/C
(311) polymorphism that has been studied in conjunc-
tion with the presence of ultrasonographic plaques.
PON 2 was unrelated to either the presence or absence
of plaques. This result agrees with those reported for
Fig. 2. Odds ratio and 95% CI obtained by logistic regression analysis of common carotid plaques, PON 1 (M/L, Q/R), PON 2 (S/C) polymorphisms,
physical and biochemical parameters (quartile 4 versus quartiles 1/3) in the study sample. The data were adjusted for age, smoking, LDL cholesterol
and BMI. Statistically significant association was found only among PON 1 (LL/ML) genotypes and upper quartile 4 of values for the parameters:
systolic blood pressure and oxidized LDL antibodies.
Table 4
Multivariate analysis using ‘Plaque score’ as dependent variable and
genetic polymorphisms of PON 1 (M/L, Q/R), PON 2 (S/C), physical
and biochemical parameters* as independent variables in the study
sample of middle-aged women of South Italy
Coefficient ‘b ’9/ES P
Independent variables a
PON 1 (LL/ML) 55 genotypes 0.739/0.29 B/0.05
Systolic blood pressure 0.469/0.21 B/0.05
Dependent variable/‘Plaque score’
*Quartile 4 versus Quartiles 1/3.
a Adjusted for age, smoking, LDL cholesterol and BMI.
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African Caribbeans [14]. However, the SS genotype was
more frequent in cases of IMTB/1.2 mm versus IMT/
1.2 mm, which is in accordance with data obtained in a
Japanese population [12]. In contrast, another report
suggested that PON 2 SS (311) contributes synergisti-
cally to the PON 1 RR (192) genotype as a risk factor
for CVD [6]. It is noteworthy that in previous studies the
PON 2 polymorphism was evaluated both in cardiovas-
cular and control subjects in whom plaques were not
measured [6,12]. Therefore, misclassification due to
possible subclinical atherosclerosis cannot be excluded.
In conclusion, our data obtained in middle-aged
women from South Italy, provide direct evidence that
PON 1 (LL/ML) 55 genotypes play a role in carotid
lesions at any site, independently of traditional and non-
traditional risk factors. PON 1 Q/R (192) and/or PON 2
S/C (311) polymorphisms do not appear to be involved
in the development of atherosclerotic plaques.
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